Connect with us
The firm added the brain drug to its IP as it tees up FDA approval for its “trip-free” EB-003. Enveric Biosciences (NASDAQ: ENVB) has received a...
The company indicated that early test results are expected in August. Revive Therapeutics Ltd. (OTCQB: RVVTF) (CSE: RVV) released an update on the research study evaluating...
Irwin tried to buy Serenity Clinics in its failed attempt to expand into psychedelics. In addition to the East West Bank not seeing any money from...
The U.S. Food and Drug Administration widened its warning about Diamond Shruumz edible products linked to illnesses across multiple states, with a nationwide recall underway. California-based...
Psychedelic drug company Lykos Therapeutics wasn’t too happy with the Final Evidence Report issued by the Institute for Clinical and Economic Review (ICER) on its Midomafetamine...
Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) reported audited financial results for its fiscal year ended March 31, 2024. The company does not have any...
The tech startup wants to address veteran suicide and mental health needs. Mental health technology firm INVI MindHealth secured $1.5 million in seed funding, the startup...
Canadian psychedelics firm MindBio Therapeutics Corp. (CSE: MBIO) on Friday released durability results from its Phase 2A trial for its patented take-home microdose version of lysergic...
Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF) has signed a letter of intent to buy MedBright AI Investments Inc. in an all-stock deal. In addition to...
Privately owned psychedelic therapy company Mindbloom announced the positive findings of the largest peer-reviewed study regarding ketamine therapy and psychedelic medicine. The study, published in the Journal of...
